Inadequate attention has been given to the psychosocial care of patients with cancer who have completed active treatment and are identified as survivors.1,2 Cancer survivors are vulnerable to distress on completion of treatment because of the reduced frequency of clinician visits, the change in daily routines, adjustment to treatment-related side effects, unease about the future and concern about potential recurrence of the disease.3
To be effective, screening for distress requires a systematic approach.4 In the absence of formalised screening procedures, studies have shown that health professionals were unskilled at recognising clinically significant distress in patients with cancer and cancer survivors.5,6 Distress in patients with cancer and cancer survivors is often under-recognised by health professionals,7 and remains unexamined unless symptoms or signs are observed in a troubled patient or disclosed by patients themselves.
Colorectal cancer (CRC) was chosen for three reasons. First, it is the second most frequently diagnosed cancer in Australia.8 Second, it is often stigmatised because it involves more intimate parts of the body, bodily functions and potential changes in quality of life with a reorientation of bowel habits.9 Third, limited research has been undertaken to address the unmet psychological needs of people affected by CRC, particularly in the period beyond completion of treatment.10
Cancer helpline nurses have postgraduate qualifications in oncology, palliative care or both, including counselling, and have a minimum of 5 years’ clinical oncology experience. The helpline information and support program is structured on the clinical practice guidelines for the psychosocial care of adults with cancer by the National Breast Cancer Centre and National Cancer Control Initiative,11 and focuses on a patient-centred approach.12 An ongoing training and education program is provided to staff. All calls are recorded and reviewed for quality assurance.
Following the standardised intervention protocol, the nurse telephoned participants 7–10 days after recruitment (outcall one) and 4 weeks later (outcall two). During both calls, the helpline nurse administered the Distress and Impact Thermometer (DIT),13,14 provided tailored information, support and resources, and referred participants with distress levels of 5 or higher to psycho-oncology services at the patient’s health service. The DIT is a brief screening tool for the detection of distress and/or major depression.13,14 It is a two-item self-rated scale that rates the level and impact of distress. Each “distress” and “impact” question is scored along an 11-point scale, and the scores range from zero to 10, with scores of 5 or higher for distress and 4 or higher for impact reflecting moderate to severe distress that warrants follow-up care.14 This tool has shown high performance14 and is feasible for use by community-based cancer helpline operators to screen callers for distress.15 The cancer nurse at the Cancer Council Victoria’s helpline referred participants with elevated distress levels to their treating health service’s psycho-oncology service for follow-up care, and requested permission from the participant to send a letter to the patient’s nominated general practitioner to advise of the screening process and outcome. The helpline nurse telephoned the psycho-oncology staff, with a follow-up email, advising them of the patient’s contact details and DIT score. The project coordinator was in regular contact with the helpline nurse and health service psycho-oncology staff to monitor the intervention and discuss specific issues.
Study questionnaires were self-administered at baseline and administered through a telephone interview by an experienced interviewer one month after outcall two. The main outcome measure was anxiety and depression, measured using the Hospital Anxiety and Depression Scale (HADS).16 The HADS consists of two subscales, one assessing depression (seven items) and the other assessing anxiety (seven items), with scores ranging from zero (no distress) to 21 (maximum distress) for each scale. Scores of 11 or higher on either subscale are considered to indicate a significant “case” of psychological morbidity, scores of 8–10 represent borderline morbidity and 0–7 reflect a normal range.17,18 The HADS has been used in many research settings and clinical studies, particularly for patients with cancer.19
Overall, 59 (87%) of the 68 patients with CRC who were approached agreed to participate. Forty-five participants completed both interventions and the follow-up interview. Reasons for loss to follow-up included: significant illness; could not be contacted; deceased; and restarted chemotherapy (Box 1). There were no significant differences between those who did and did not complete follow-up in terms of age, sex, baseline anxiety and depression, and distress.
Box 2 shows that there were more men than women. Participants’ ages ranged from 33 to 77 years, the average being 59 years (SD, 9.5 years). Three-quarters of participants were married or in a de facto relationship, and most participants were born in Australia and were either retired or working full-time (Box 2).
Although mean levels of anxiety and depression at baseline were within the normal range, HADS depression decreased significantly from baseline (mean score, 4.93; SD, 4.22; n = 45) to follow-up (mean score, 3.84; SD, 4.10; n = 45; Z = − 2.375; P = 0.02). At baseline, nine participants scored 8–10, representing borderline clinical levels of depression, and a further five scored 11 and over, representing significant psychological morbidity. At follow-up, one participant had borderline clinical levels of depression and five had significant psychological morbidity.
Satisfaction with the program among par-ticipants was high, with 82% reporting out-call one “quite or very helpful” and 79% reporting outcall two “quite or very help-ful”. With regard to outcall one, participants reported that they “took comfort” in the support provided by the call, that it was “good to have someone to chat to” and also that it was helpful “to discuss issues that I was uncertain about”. Overall, 30% of participants took action as a result of this call, including joining a support group, increasing or decreasing physical activity and contacting their oncologist about physical symptoms. Participants reported that outcall two was particularly important, as they had had no contact with medical practitioners since completing their treatment, had a “feeling of abandonment” and welcomed the emotional support and reassurance of discussing issues with the cancer nurse. Participants also reported that they “did not want to burden family and friends” with their problems. Participants were asked in what ways the calls helped them. As shown in Box 3, most reported that the calls helped them think things through (69%) and helped them think positively about their situation (61%).
This was a feasibility study, hence the sample was small. Although the response rate was high, the number of eligible patients recruited into the study was lower than anticipated. Although we monitored recruitment across the sites and requested that all eligible patients be approached to participate, we cannot be certain that the oncology nurses adhered to this request at all times. As not all health services have patient databases and some patients in the private system completed treatment without the oncology nurses being told of their final completion date, we were unable to ascertain the number of patients with CRC who completed their treatment within the recruitment period, and therefore cannot determine potential selection bias. While there was high participation at both outcalls, demonstrating the feasibility and acceptability of the intervention, there was also a moderate attrition rate over time with participants either too ill or unable to be contacted during the follow-up period. Other studies have demonstrated similar decreases.20 A future trial would need to take into account these recruitment and attrition issues.
- Patricia M Livingston1
- Melinda J Craike2
- Victoria M White2
- Amanda J Hordern2
- Michael Jefford2,3,4
- Mari A Botti1
- Carrie Lethborg5
- John C Oldroyd6
- 1 Faculty of Health, Medicine, Nursing and Behavioural Sciences, Deakin University, Melbourne, VIC.
- 2 Cancer Council Victoria, Melbourne, VIC.
- 3 Peter MacCallum Cancer Centre, Melbourne, VIC.
- 4 University of Melbourne, Melbourne, VIC.
- 5 St Vincent’s Hospital (Melbourne), Melbourne, VIC.
- 6 Cabrini Institute, Cabrini Health, Melbourne, VIC.
This study was funded by beyondblue: the national depression initiative and the Victorian Cancer Agency. We thank Suzanne Grogan of Cancer Council Victoria’s Cancer Information and Support Service for undertaking the intervention at the cancer helpline and Bronwyn Nixon, who administered the follow-up telephone questionnaires. We appreciate the time taken by the participants who took part in the study and acknowledge the time taken by the oncology staff in assisting with the identification and recruitment of patients, and psychologists and social workers involved in the intervention. We also acknowledge the North Eastern Metropolitan Integrated Cancer Service, which supported this project.
None identified.
- 1. Holland JC, Reznik I. Pathways for psychosocial care of cancer survivors. Cancer 2005; 104: 2624-2637.
- 2. Feuerstein M. Defining cancer survivorship. J Cancer Surviv 2007; 1: 5-7.
- 3. Kornblith AB. Psychosocial adaptation of cancer survivors. In: Holland JC, editor. Psychooncology. New York: Oxford University Press, 1998: 223-254.
- 4. Andrykowski MA, Lykins EM, Floyd A. Psychological health in cancer survivors. Semin Oncol Nurs 2008; 24: 193-201.
- 5. Hordern AJ, Street AF. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust 2007; 186: 224-227. <MJA full text>
- 6. Samers JM, Galetakis S, Scott CJ, et al. Breast cancer management: the perspective of general practitioners in inner and eastern Melbourne. Breast 2004; 13: 468-475.
- 7. Fallowfield L, Ratcliffe D, Jenkins V, et al. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001; 84: 1011-1015.
- 8. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia: an overview, 2008. Cancer series no. 46. Canberra: AIHW, 2008. (AIHW Cat. No. CAN 42.) http://www.aihw.gov.au/publications/index.cfm/title/10607 (accessed Jun 2010).
- 9. Rozmovits L, Ziebland S. Expressions of loss of adulthood in the narratives of people with colorectal cancer. Qual Health Res 2004; 14: 187-203.
- 10. Institute of Medicine. From cancer patient to cancer survivor: lost in transition. Washington: National Academies, 2005.
- 11. National Breast Cancer Centre and National Cancer Control Initiative. Clinical practice guidelines for the psychosocial care of adults with cancer. Sydney: National Breast Cancer Centre, 2003.
- 12. Turner J, Zapart S, Pedersen K, et al; National Breast Cancer Centre, Sydney, Australia; National Cancer Control Initiative, Melbourne, Australia. Clinical practice guidelines for the psychosocial care of adults with cancer. Psychooncology 2005; 14: 159-173.
- 13. Shimizu K, Akechi T, Okamura M, et al. Usefulness of the nurse-assisted screening and psychiatric referral program. Cancer 2005; 103: 1949-1956.
- 14. Akizuki N, Yamawaki S, Akechi T, et al. Development of an impact thermometer for use in combination with the Distress Thermometer as a brief screening tool for adjustment disorders and/or major depression in cancer patients. J Pain Symptom Manage 2005; 29: 91-99.
- 15. Hawkes AL, Hughes KL, Hutchison SD, Chambers SK. Feasibility of brief psychological distress screening by a community-based telephone helpline for cancer patients and carers. BMC Cancer 2010; 10: 14.
- 16. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-370.
- 17. Kugaya A, Akechi T, Okuyama T, et al. Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer 2000; 88: 2817-2823.
- 18. Hopwood PH, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 1991; 64: 353-356.
- 19. Love AW, Grabsch B, Clarke DM, et al. Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry 2004; 38: 526-531.
- 20. Young J, Harrison J, Solomon M, et al. Development and feasibility assessment of telephone-delivered supportive care to improve outcomes for patients with colorectal cancer: pilot study of the CONNECT intervention. Support Care Cancer 2010; 18: 461-470.
Abstract
Objective: To test the feasibility and acceptability of a telephone-based program to screen survivors of colorectal cancer (CRC) for distress, and to refer distressed patients to their treating health service.
Design, setting and participants: A prospective, multicentre study involving 59 patients with CRC recruited from six public and private health services in Melbourne, Victoria, from 15 June 2008 to 22 September 2009. Patients who had completed adjuvant chemotherapy for CRC were contacted (7–10 days after recruitment [outcall one] and again 4 weeks later [outcall two]) by the Cancer Council Victoria’s helpline nurse, and screened for distress with the Distress and Impact Thermometer (DIT); participants were given tailored information and support and those with distress scores of ≥ 5, and impact scores of ≥ 4, were referred for follow-up. Telephone interviews were conducted 4 weeks after outcall two. Participating helpline and health service staff were surveyed on the feasibility and acceptability of the service.
Main outcome measure: Anxiety and depression, measured by the Hospital Anxiety and Depression Scale (HADS).
Results: Of the 59 patients (87%) who agreed to participate, 63% were men; their mean age was 59 years (SD, 9.5 years). HADS depression decreased significantly from baseline (mean score, 4.93; SD, 4.22) to follow-up (mean score, 3.84; SD, 4.10; Z = − 2.375; P = 0.02). However, there was no significant difference in HADS anxiety between baseline (mean score, 5.29; SD, 4.11) and follow-up (mean score, 4.78; SD, 3.65). Outcall one generated two referrals (4% of participants) and outcall two generated four referrals (8%); five of these six participants took up the referrals. Satisfaction with the program among participants was high; 82% found outcall one “quite or very helpful” and 79% found outcall two “quite or very helpful”. Helpline and health service staff reported a straightforward process that did not adversely affect workloads.
Conclusion: This model of care carries the potential to meet ongoing psychosocial needs of survivors of CRC.